bioimagingsolutions

Cloning and characterization of a novel DNase gene

Cloning and characterization of a novel DNase gene from Trichogramma pretiosum

DNase is a strong device for a collection of molecular biology functions. Growing a technique for large-scale manufacturing of DNase with excessive purity and exercise is vital for scientific analysis. On this examine, a beforehand uncharacterized gene with nuclease exercise was present in Trichogramma pretiosum genome.

Pichia pastoris GS115 was most popular because the host to beat the problems associated to prokaryotic expression. Below the optimum circumstances, the exercise of T. pretiosum DNase (Tp-DNase) reached 1940 U/mL of tradition supernatant in fed-batch fermentation. Utilizing ion-exchange chromatography and adsorption chromatography, Tp-DNase was produced with a purity of > 99% and molecular weight of 45 kDa.

In vitro DNA degradation experiments confirmed that Tp-DNase might successfully degrade dsDNA, and its exercise was barely greater than that of bovine pancreas DNase I beneath the identical circumstances. Furthermore, Tp-DNase can be utilized to get rid of nucleic acid contamination and enhance the accuracy of nucleic acid detection.

Molecular cloning and characterization of a thermostable and halotolerant endo-β-1,4-glucanase from Microbulbifer sp. ALW1

The bacterium Microbulbifer sp. ALW1 was beforehand characterised with the aptitude to interrupt down the cell wall of brown algae into fantastic items. The organic capabilities of pressure ALW1 had been but to be elucidated. On this examine, a gene, particularly MaCel5A, was remoted from the ALW1 pressure genome, encoding an endo-β-1,4-glucanase. MaCel5A was phylogenetically categorized beneath the glycoside hydrolase household GH5, with the best identification to a putative cellulase of Microbulbifer thermotolerans. The recombinant MaCel5A protein purified from heterologous expression in E. coli exhibited most exercise at 50 °C and pH 6.0, respectively, and functioned selectively towards carboxymethyl cellulose and barley β-glucan.

Recombinant MaCel5A demonstrated appreciable tolerance to the publicity to excessive temperature as much as 80 °C for 30 min retaining 49% residual exercise. As well as, MaCel5A confirmed reasonable stability in opposition to pH 5.0-11.Zero and powerful stability within the presence of nonionic surfactant. MaCel5A exhibited robust halo-stability and halotolerance.

The exercise of the enzyme elevated about tenfold at 0.5 M NaCl, and about fivefold even at 4.Zero M NaCl in comparison with the enzyme exercise with out the addition of salt. The 2 conserved glutamic acid residues in MaCel5A featured the standard catalytic acid/base and nucleophile equipment of glycoside hydrolases. These traits spotlight the commercial software potential of MaCel5A.

bioimagingsolutions
bioimagingsolutions

CD27, Fc fusion

71176 100 µg
EUR 320
Description: Human secreted CD27, Fc fusion protein, also known as Tumor Necrosis Factor Receptor Superfamily Member 7, TNFRSF7, and T14, GenBank Accession No. NM_001242, a.a. 21-192 expressed in a HEK293 cell expression system. MW = 45.8 kDa (monomer). This protein runs at a higher MW by SDS-PAGE due to glycosylation.

CD47, Fc fusion

71177 100 µg
EUR 325
Description: Human CD47, Fc fusion protein, also known as leukocyte surface antigen CD47, Rh-related antigen, integrin-associated protein, antigenic surface determinant protein OA3, antigen identified by monoclonal antibody 1D8, IAP, and MER6. GenBank Accession No. NM_001777, a.a. 19-139 expressed in a HEK293 cell expression system. MW = 40 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (AP)

MBS6278824-02mL 0.2mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (AP)

MBS6278824-5x02mL 5x0.2mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (PE)

MBS6278834-02mL 0.2mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (PE)

MBS6278834-5x02mL 5x0.2mL
EUR 4250

Eppendorf Multiporator Helix Fusion Chamber For Cell Fusion - EACH

E4308014008 EACH
EUR 1150.2

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (APC)

MBS6278825-02mL 0.2mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (APC)

MBS6278825-5x02mL 5x0.2mL
EUR 4250

TIGIT, Fc fusion

71186 100 µg
EUR 320
Description: Human T-cell immunoreceptor with Ig and_x000D_ITIM domains (TIGIT), also known as V-set_x000D_and immunoglobulin domain-containing_x000D_protein 9, VSIG9, V-set and transmembrane_x000D_domain-containing protein 3, and VSTM3,_x000D_GenBank Accession No. NM_173799, a.a._x000D_22-141 fused to Fc region of human IgG,_x000D_expressed in a HEK293 cell expression_x000D_system. MW = 39.7 kDa. This protein runs_x000D_at a higher MW by SDS-PAGE due to_x000D_glycosylation.

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (FITC)

MBS6278827-02mL 0.2mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (FITC)

MBS6278827-5x02mL 5x0.2mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (Biotin)

MBS6278826-02mL 0.2mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (Biotin)

MBS6278826-5x02mL 5x0.2mL
EUR 4250

Fusion (FUS) Antibody

20-abx110192
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Fusion (FUS) Antibody

20-abx100040
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Fusion (FUS) Antibody

20-abx129140
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Fusion (FUS) Antibody

20-abx212423
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Fusion (FUS) Antibody

20-abx212424
  • Ask for price
  • Ask for price
  • 100 ul
  • 50 ul

Fusion (FUS) Antibody

20-abx172487
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Fusion (FUS) Antibody

20-abx176518
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

FUS (Fusion) Antibody

E301249 100ug
EUR 275
Description: Available in various conjugation types.

FUS (Fusion) Antibody

E301250 100ug/200ul
EUR 275
Description: Available in various conjugation types.

FUS (Fusion) Antibody

MBS851844-01mg 0.1mg
EUR 345

FUS (Fusion) Antibody

MBS851844-01mLAF405L 0.1mL(AF405L)
EUR 565

FUS (Fusion) Antibody

MBS851844-01mLAF405S 0.1mL(AF405S)
EUR 565

FUS (Fusion) Antibody

MBS851844-01mLAF610 0.1mL(AF610)
EUR 565

FUS (Fusion) Antibody

MBS851844-01mLAF635 0.1mL(AF635)
EUR 565

FUS (Fusion) Antibody

MBS853275-01mg 0.1mg
EUR 345

FUS (Fusion) Antibody

MBS853275-01mLAF405L 0.1mL(AF405L)
EUR 565

FUS (Fusion) Antibody

MBS853275-01mLAF405S 0.1mL(AF405S)
EUR 565

FUS (Fusion) Antibody

MBS853275-01mLAF610 0.1mL(AF610)
EUR 565

FUS (Fusion) Antibody

MBS853275-01mLAF635 0.1mL(AF635)
EUR 565

Morpheus Fusion FX

M-MD1-130-FX 96 x 100 ul ul
EUR 67
Description: Morpheus Fusion FX

GST (fusion protein)

MBS395035-01mg 0.1mg
EUR 425

GST (fusion protein)

MBS395035-5x01mg 5x0.1mg
EUR 1760

hCD70-muCD8 Fusion Protein (human CD70-murine CD8 Fusion Protein)

MBS634480-0025mg 0.025mg
EUR 825

hCD70-muCD8 Fusion Protein (human CD70-murine CD8 Fusion Protein)

MBS634480-5x0025mg 5x0.025mg
EUR 3560

Recombinant Fusion (FUS)

RPC260Hu01 10ug
EUR 164

Recombinant Fusion (FUS)

4-RPC260Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Fusion expressed in: E.coli

Recombinant Fusion (FUS)

RPC260Mu01 10ug
EUR 180

Recombinant Fusion (FUS)

4-RPC260Mu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Fusion expressed in: E.coli

Recombinant Fusion (FUS)

RPC260Mu02 10ug
EUR 140

Recombinant Fusion (FUS)

RPU57089-100ug 100ug
EUR 470.4

Recombinant Fusion (FUS)

RPU57089-1mg 1mg
EUR 2184

Recombinant Fusion (FUS)

RPU57089-50ug 50ug
EUR 385

Recombinant Fusion (FUS)

RPU51790-100ug 100ug
EUR 504.9

Recombinant Fusion (FUS)

RPU51790-1mg 1mg
EUR 2238.6

Recombinant Fusion (FUS)

RPU51790-50ug 50ug
EUR 405.9

Recombinant Fusion (FUS)

RPU41541-100ug 100ug
EUR 554.4

Recombinant Fusion (FUS)

RPU41541-1mg 1mg
EUR 2457

Recombinant Fusion (FUS)

RPU41541-50ug 50ug
EUR 445.5

Recombinant Fusion (FUS)

MBS2030542-001mg 0.01mg
EUR 165

Recombinant Fusion (FUS)

MBS2030542-005mg 0.05mg
EUR 290

Recombinant Fusion (FUS)

MBS2030542-01mg 0.1mg
EUR 435

Recombinant Fusion (FUS)

MBS2030542-02mg 0.2mg
EUR 525

Recombinant Fusion (FUS)

MBS2030542-05mg 0.5mg
EUR 1005

Recombinant Fusion (FUS)

MBS2009793-001mg 0.01mg
EUR 175

Recombinant Fusion (FUS)

MBS2009793-005mg 0.05mg
EUR 310

Recombinant Fusion (FUS)

MBS2009793-01mg 0.1mg
EUR 470

Recombinant Fusion (FUS)

MBS2009793-02mg 0.2mg
EUR 575

Recombinant Fusion (FUS)

MBS2009793-05mg 0.5mg
EUR 1090

Recombinant Fusion (FUS)

MBS2122937-001mg 0.01mg
EUR 155

Recombinant Fusion (FUS)

MBS2122937-005mg 0.05mg
EUR 260

Recombinant Fusion (FUS)

MBS2122937-01mg 0.1mg
EUR 375

Recombinant Fusion (FUS)

MBS2122937-02mg 0.2mg
EUR 460

Recombinant Fusion (FUS)

MBS2122937-05mg 0.5mg
EUR 860

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 405)

MBS6278829-01mL 0.1mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 405)

MBS6278829-5x01mL 5x0.1mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 490)

MBS6278830-01mL 0.1mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 490)

MBS6278830-5x01mL 5x0.1mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 550)

MBS6278831-01mL 0.1mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 550)

MBS6278831-5x01mL 5x0.1mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 650)

MBS6278832-01mL 0.1mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 650)

MBS6278832-5x01mL 5x0.1mL
EUR 4250

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 750)

MBS6278833-01mL 0.1mL
EUR 980

BRD4, CT (BRD4-NUT fusion oncoprotein, BRD4-NUT FUSION) (MaxLight 750)

MBS6278833-5x01mL 5x0.1mL
EUR 4250

Fusion glycoprotein F0

E8ER1802-33 100ul
EUR 275
Description: Available in various conjugation types.

Fusion glycoprotein F0

E8ER1803-51 100ul
EUR 275
Description: Available in various conjugation types.

Fusion glycoprotein F0

MBS7043592-002mg 0.02mg
EUR 1875

Fusion glycoprotein F0

MBS7043592-01mg 0.1mg
EUR 2810

Fusion glycoprotein F0

MBS8565322-01mL 0.1mL
EUR 345

Fusion glycoprotein F0

MBS8565322-01mLAF405L 0.1mL(AF405L)
EUR 565

Fusion glycoprotein F0

MBS8565322-01mLAF405S 0.1mL(AF405S)
EUR 565

Fusion glycoprotein F0

MBS8565322-01mLAF610 0.1mL(AF610)
EUR 565

Fusion glycoprotein F0

MBS8565322-01mLAF635 0.1mL(AF635)
EUR 565

Fusion glycoprotein F0

MBS8565443-01mL 0.1mL
EUR 345

Fusion glycoprotein F0

MBS8565443-01mLAF405L 0.1mL(AF405L)
EUR 565

Fusion glycoprotein F0

MBS8565443-01mLAF405S 0.1mL(AF405S)
EUR 565

Fusion glycoprotein F0

MBS8565443-01mLAF610 0.1mL(AF610)
EUR 565

Cloning and bodily localization of male-biased repetitive DNA sequences in Spinacia oleracea (Amaranthaceae)

Spinach (Spinacia oleracea Linnaeus, 1753) is a perfect materials for finding out molecular mechanisms of early-stage intercourse chromosome evolution in dioecious vegetation. Degenerate oligonucleotide-primed polymerase chain response (DOP-PCR) approach facilitates the retrotransposon-relevant research by enriching particular repetitive DNA sequences from a micro-dissected single chromosome. We carried out genomic subtractive hybridization to display sex-biased DNA sequences through the use of the DOP-PCR amplification merchandise of micro-dissected spinach Y chromosome.

The screening yielded 55 male-biased DNA sequences with 30 576 bp in size, of which, 32 DNA sequences (12 049 bp) contained repeat DNA sequences, together with LTR/CopiaLTR/Gypsy, easy repeats, and DNA/CMC-EnSpm. Amongst these repetitive DNA sequences, 4 DNA sequences that contained a fraction of Ty3-gypsy retrotransposons (SP73, SP75, SP76, and SP77) had been chosen as fluorescence probes to hybridization on female and male spinach karyotypes.

Fluorescence in situ hybridization (FISH) alerts of SP73 and SP75 had been captured totally on the centromeres and their surrounding space for every homolog. Hybridization alerts primarily appeared close to the putative centromeres for every homologous chromosome pair through the use of SP76 and SP77 probes for FISH, and sporadic alerts existed on the lengthy arms. Outcomes may be served as a foundation to check the perform of repetitive DNA sequences in intercourse chromosome evolution in spinach.

Molecular cloning and practical characterization of TaIRI9 gene in wheat (Triticum aestivum L.)

The vernalization of wheat is without doubt one of the necessary elements that decide the planting area, introduction and cultivation methods of wheat. Nevertheless, the recognized vernalization genes (molecular marker) can’t exactly distinguish the vernalization requirement of winter wheat cultivars. Subsequently, it is very important discover new vernalization genes and elucidate the mechanism of vernalization regulation.

To discover the gene community within the vernalization pathway, we screened TaIRI9 (ice recrystallization inhibitor protein) gene related to the expression profile of vernalization therapy of winter wheat Jing 841. Overexpression of TaIRI9 in wild kind wheat resulted in lowered plant top, elevated tiller quantity and delayed heading days.

After 4°C vernalization therapy for 30, 35, 45 or 50 days, TaIRI9 overexpression strains confirmed elevated vernalization requirement and delayed heading time than wild kind, indicating that TaIRI9 could have an effect on vernalization strategy of wheat. As well as, the expression of the TaIRI9 genes had been analyzed in winter Jing 841, robust winter wheat cultivar Xindong 18 and ten recombinant inbred strains (RILs, Hussar x Yanzhan1).

The information confirmed that the expression of TaIRI9 was positively related to the requirement of vernalization. These outcomes indicated that TaIRI9 regulates heading and flowering time in wheat by selling VRN2 and inhibiting flowering promoter VRN1 and VRN3 and could also be concerned in wheat vernalization regulation pathway. Bulked segregant CGT-Seq-facilitated map-based cloning of a powdery mildew resistance gene originating from wild emmer wheat (Triticum dicoccoides)

Powdery mildew, attributable to Blumeria graminis f. sp. tritici (Bgt), is a extensively occurring foliar illnesses of wheat worldwide. Wild emmer wheat (WEW, Triticum dicoccoides) (AABB, 2n=4x=28), the progenitor of the cultivated tetraploid and hexaploid wheat, is extremely proof against powdery mildew and plenty of resistance alleles had been recognized on this wild species.

Cloning, expression, and characterization of Baeyer-Villiger monooxygenases from eukaryotic Exophiala jeanselmei pressure KUFI-6N

The fungus Exophiala jeanselmei pressure KUFI-6N produces a singular cycloalkanone monooxygenase (ExCAMO) that shows an unusual substrate spectrum of Baeyer-Villiger oxidation of 4-10-membered ring ketones. On this examine, we aimed to determine and sequence the gene encoding ExCAMO from KUFI-6N and overexpress the gene in Escherichia coli.

We discovered that the first construction of ExCAMO is most carefully associated to the cycloalkanone monooxygenase from Cylindrocarpon radicicola ATCC 11011, with 54.2% amino acid identification. ExCAMO was functionally expressed in Escherichia coli and its substrate spectrum and kinetic parameters investigated.

Substrate profiling indicated that ExCAMO is uncommon amongst recognized Baeyer-Villiger monooxygenases owing to its capability to simply accept quite a lot of substrates, together with C4-C12 membered ring ketones. ExCAMO has excessive affinity and catalytic effectivity towards cycloalkanones, the best being towards cyclohexanone. 5 different genes encoding Baeyer-Villiger monooxygenases had been additionally cloned and expressed in Escherichia coli.